Research Article
Xiaotan Jieyu Prescription Alleviates Breast Precancerous Lesions through PI3K/Akt Signaling Pathway
Table 3
The number of visible breast tumors in each group after treatment for 4 weeks.
| | Groups | Number of tumors | Incidence rate |
| | BLA (n = 20) | 0 | 0 | | MOD (n = 20) | 18 | 90% | | LD (n = 19) | 14 | 73.7% | | MD (n = 19) | 12 | 63.2% | | HD (n = 20) | 9 | 45.0% | | TAM (n = 20) | 10 | 50.0% |
|
|
